chr5-76195028-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014979.4(SV2C):c.690C>A(p.Phe230Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,614,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014979.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SV2C | NM_014979.4 | c.690C>A | p.Phe230Leu | missense_variant | 3/13 | ENST00000502798.7 | NP_055794.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SV2C | ENST00000502798.7 | c.690C>A | p.Phe230Leu | missense_variant | 3/13 | 1 | NM_014979.4 | ENSP00000423541 | P1 | |
SV2C | ENST00000322285.7 | c.690C>A | p.Phe230Leu | missense_variant | 3/13 | 2 | ENSP00000316983 |
Frequencies
GnomAD3 genomes AF: 0.000742 AC: 113AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 249552Hom.: 0 AF XY: 0.0000886 AC XY: 12AN XY: 135394
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461786Hom.: 0 Cov.: 30 AF XY: 0.0000454 AC XY: 33AN XY: 727198
GnomAD4 genome AF: 0.000742 AC: 113AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000765 AC XY: 57AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.690C>A (p.F230L) alteration is located in exon 3 (coding exon 2) of the SV2C gene. This alteration results from a C to A substitution at nucleotide position 690, causing the phenylalanine (F) at amino acid position 230 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at